“Join the Fight Against Securities Fraud: Investors Can Take Action in Kyverna Therapeutics Inc. Lawsuit”

Global Investor Rights Law Firm Reminds Purchasers of Kyverna Therapeutics, Inc. Common Stock of Lead Plaintiff Deadline New York, Jan. 21, 2025 /PRNewswire/ Why Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna’s initial public offering conducted on February…

Read More

“Legal Troubles Send Walgreens Stock Tumbling: A Setback for Investors’ Hopes of a Comeback”

Walgreens (WBA) Sets the Tone for 2025 A Promising Start After a Tough Year After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poised to start 2025 on a strong note after the company’s first-quarter results topped expectations. The pharmaceutical giant managed to beat analyst estimates, reporting strong revenue growth…

Read More

“Attention APLT Investors: Important Announcement from Robbins Geller Rudman & Dowd LLP Regarding Applied Therapeutics Inc. Securities Class Action Lawsuit”

Robbins Geller Rudman & Dowd LLP Announces Deadline for Applied Therapeutics, Inc. Investors Seeking Lead Plaintiff for Class Action Lawsuit SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) Investors who purchased or acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, have until Tuesday, February 18, 2025 to seek appointment…

Read More